JPRN-UMIN000000651
Completed
Phase 2
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2 - Phase II study of Neoadjuvant Chemotherapy / Tmab for HER2-positive BC
Office for cordination of Herceptin trial0 sites100 target enrollmentMarch 23, 2007
ConditionsBreast Cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Office for cordination of Herceptin trial
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Pregnant and nursing 2\. Concomitant infectious disease 3\. History of hypersensitivity to Cremophor EL(polyoxethylated castor oil) or polysorbate 4\. Interstitual pneumonia or lung fibrosis 5\. Hepatitis Virus B antigen positive 6\. Diabetes Mellitus with uncontrolled status or insulin\-therapy 7\. Difficulty to participate because of mental disorder 8\. Simultaneous double\-cancer (exclude carcinoma in situ)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-001085-37-FRInstitut Bergonié66
Completed
N/A
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70
Recruiting
Phase 2
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancerResectable pancreatic cancerJPRN-UMIN000009822Chiba study group of adjuvant chemotherapy for pancreatic cancer74
Recruiting
N/A
Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutmentresectable pancreatic cancer with less than 180 degree portal vein abutmentJPRN-UMIN000027633agoya University, Graduate School of Medicine56
Active, Not Recruiting
Phase 1
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004515-45-ESFundación GECP90